Bolt Biotherapeutics BOLT

$ 4.5 4.17%

Quarterly report 2025-Q3
added 11-12-2025

Country	USA
IPO year	2021
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	37.8 M
Market Cap^[1]	$ 170 M
EBITDA (LTM)	$ -54.5 M
P/E (LTM)	-0.16
P/S (LTM)	26.57
EPS (LTM)	-27.23

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.